Currency in USD
| Earnings Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| Low Estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| High Estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| Year Ago EPS | -0.6 | -0.69 | -2.71 | -3.43 |
| Revenue Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 650k | 670k | 2.7M | 1.8M |
| Low Estimate | 650k | 670k | 2.7M | 1.8M |
| High Estimate | 650k | 670k | 2.7M | 1.8M |
| Year Ago Sales | 606k | 651k | 2.54M | 2.7M |
| Sales Growth (year/est) | 7.30% | 2.90% | 6.30% | -33.30% |
| Earnings History | 2023-03-30 | 2023-06-29 | 2023-09-29 | 2023-12-30 |
|---|
| EPS Est. | -1.1 | -1.13 | -1.12 | -0.87 |
| EPS Actual | -0.6 | -0.69 | -0.69 | -0.77 |
| Difference | 0.5 | 0.44 | 0.43 | 0.1 |
| Surprise % | 45.50% | 38.90% | 38.40% | 11.50% |
| EPS Trend | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Current Estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| 7 Days Ago | -0.79 | -0.83 | -3.43 | -0.82 |
| 30 Days Ago | -0.79 | -0.83 | -3.43 | -0.82 |
| 60 Days Ago | 0 | 0 | -0.64 | -0.93 |
| 90 Days Ago | 0 | 0 | -0.64 | -0.93 |
| EPS Revisions | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | N/A | N/A | N/A | N/A |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | XBIO | Industry | Sector(s) | S&P 500 |
|---|
| Current Qtr. | -31.70% | N/A | N/A | N/A |
| Next Qtr. | -20.30% | N/A | N/A | N/A |
| Current Year | -26.60% | N/A | N/A | N/A |
| Next Year | 76.10% | N/A | N/A | N/A |
| Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 Years (per annum) | N/A | N/A | N/A | N/A |
